Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
D-Tagatose
Cat. No.:
0225LY-1396
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
D-Tagatose is a rare natural hexoketose and galactose isomer with various health benefits, including weight loss promotion, prebiotic activity, and the reduction of symptoms in type 2 diabetes.
Synonym:
D-(-)-Tagatose; 87-81-0; (3S,4S,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; D-lyxo-hexulose; lyxo-2-Hexulose; Tagatose, D-; Naturlose; keto-D-tagatose; DL-Tagatose; D-(-)-Tagatose; REl-(3S,4S,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; Tagatose, D- (8CI)
CAS No.:
87-81-0
Compound CID:
92092
Formula:
C6H12O6
Formula Weight:
180.16
Specification
Relative Density:
1.589 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
D-Tagatose can be used in metabolic research to examine its properties as a low-calorie functional sweetener and its effect on glycemic index.
Library Information
Target:
Endogenous metabolite
Receptor:
Metabolic signaling protein
Pathways:
Metabolism
Plate Number:
AOCL-18
Plate Location:
h9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 277.53 mM
